79360498 - LIGEN

Information

• Trademark
• 79360498

• Source

• Serial Number

  79360498

• Registration Number

  7383355

• International Classifications

  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 23, 2022
  2 years ago

• Registration Date

  May 14, 2024
  8 months ago

• Transaction Date

  December 31, 2024
  a month ago

• Status Date

  May 14, 2024
  8 months ago

• Published for Opposition Date

  February 27, 2024
  11 months ago

• Location Date

  May 13, 2024
  8 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  WATTS-FITZGERALD, CAITLIN

• Attorney Docket Number

  109769.00129

  Attorney Name

  Theodore R. Remaklus

  Law Office Assigned Location Code

  M20

• Owners

  • Domp e Farmaceutici SpA

Case File Statements

• DM0000: The mark consists of the word "LIGEN" with a red dot between the L and I. The "LI" lettering appears in red, while "GEN" is in grey. To the left is a cube design in grey with a red sphere in the center, the left side of which creates a red "L" and "I," while the right side creates a grey "G". White indicates transparent matter and is not claimed as a feature of the mark.
• GS0091: Downloadable computer software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teaching, specifically, for granting user access to courses of instruction in the medical field; downloadable virtual screening software, specifically, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, and facilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models in the field of healthcare
• PM0001: LG LIGEN
• CC0000: The color(s) red and grey is/are claimed as a feature of the mark.
• GS0421: Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temporary use of online, non-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine

Case File Event Statements

• 1/19/2023 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 1/20/2023 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/24/2023 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/6/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 9/6/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/7/2023 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 9/25/2023 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 1/10/2024 - a year ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/25/2023 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 10/17/2023 - a year ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/10/2024 - a year ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/10/2024 - a year ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/11/2024 - a year ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/11/2024 - a year ago

  14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/11/2024 - a year ago

  15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/11/2024 - a year ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/11/2024 - a year ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/23/2024 - a year ago

  18 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 2/7/2024 - 12 months ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/7/2024 - 12 months ago

  19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 2/7/2024 - 12 months ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/7/2024 - 12 months ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/26/2024 - 11 months ago

  23 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 2/27/2024 - 11 months ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/14/2024 - 8 months ago

  27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 8/14/2024 - 5 months ago

  28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/7/2024 - 2 months ago

  30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 11/7/2024 - 2 months ago

  29 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/30/2024 - 2 months ago

  31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 12/26/2024 - a month ago

  35 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/26/2024 - a month ago

  32 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 12/26/2024 - a month ago

  36 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/26/2024 - a month ago

  34 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/26/2024 - a month ago

  33 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 5/14/2024 - 8 months ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/4/2024 - 11 months ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB